TFB2M and lung cancer: We employed the mutant KrasG12Dp53−/− (HKP1) orthotopic model of lung cancer, which develops adenocarcinoma with histopathological similarities to human NSCLC, in syngeneic immunocompetent C57BL/6 mice16.